T.Man Pharmaceutical PCL Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,240	5,880	-	-	-	-
Enterprise Value	4,708	6,072	-	-	-	-
Last Close Price	10.60	13.91	-	-	-	-
PE Ratio	9.11	13.05	-	-	-	-
Forward PE	8.65	11.42	-	-	-	-
PS Ratio	1.88	2.64	-	-	-	-
PB Ratio	2.21	3.32	-	-	-	-
P/TBV Ratio	2.25	3.39	-	-	-	-
P/FCF Ratio	12.10	17.01	-	-	-	-
P/OCF Ratio	8.40	11.32	-	-	-	-
EV/Sales Ratio	2.09	2.73	-	-	-	-
EV/EBITDA Ratio	7.09	9.41	-	-	-	-
EV/EBIT Ratio	8.61	11.04	-	-	-	-
EV/FCF Ratio	13.44	17.56	-	-	-	-
Debt / Equity Ratio	0.53	0.65	0.39	0.61	1.17	1.75
Debt / EBITDA Ratio	1.53	1.76	0.95	0.94	4.43	6.23
Debt / FCF Ratio	2.89	3.33	9.52	2.21	3.41	7.01
Asset Turnover	0.76	0.73	0.81	1.06	0.80	-
Inventory Turnover	2.19	2.21	2.39	2.77	2.39	-
Quick Ratio	0.85	0.67	0.94	0.76	0.34	0.28
Current Ratio	1.38	1.32	1.42	1.12	0.69	0.70
Return on Equity (ROE)	23.99%	27.40%	33.66%	58.57%	10.38%	-
Return on Assets (ROA)	11.48%	11.30%	13.38%	19.82%	3.21%	-
Return on Capital (ROIC)	13.95%	13.66%	17.31%	26.01%	3.81%	-
Return on Capital Employed (ROCE)	26.90%	29.30%	32.70%	51.60%	12.20%	12.40%
Earnings Yield	10.40%	7.66%	-	-	-	-
FCF Yield	8.26%	5.88%	-	-	-	-
Dividend Yield	1.89%	1.44%	-	-	-	-
Payout Ratio	321.01%	296.35%	2.74%	-	-	-
Buyback Yield / Dilution	-20.41%	-24.68%	-10.30%	-246.21%	-8.20%	-
Total Shareholder Return	-18.61%	-23.24%	-10.30%	-246.21%	-8.20%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.